Table 1.

Characteristics of patients

Gender (male/female)44/33
Age61 ± 13
Lymphocyte count (/mm3)1,647 ± 698
NK cells (% of lymphocytes)11 ± 7
NK cell count (/mm3)175 ± 121
Primary tumor site
    Stomach40%
    Bowel47%
    Others13%
Metastatic site(s)
    015%
    160%
    219%
    3 or more6%
c-kit mutation *
    Exon 1151%
    Exon 94%
    None17%
    Not done28%
Imatinib treatment
    400 mg81%
    800 mg19%
Mean follow up (mo)47 ± 18
  • * Assessed as reported in Emile, et al. ( 14).